Join hosts Eric Schneider and Isaac Bock in an engaging episode of "Charting New Highs," where they sit down with Lisa Rich Milan, the visionary CEO of Maridose. This episode offers an exclusive look into how Maridose is pioneering the integration of cannabis with pharmaceutical precision and navigating the complexities of licensing.

Whether you're deeply embedded in the cannabis industry or keen on its intersection with healthcare, this conversation is packed with insights on:

• Pioneering Pharmaceutical Cannabis: Lisa shares her journey from the pharmaceutical industry to leading Maridose, highlighting the innovative approaches to cannabis research and development. Discover how Maridose's work as one of the eight DEA-licensed manufacturers is setting new standards for quality and compliance in cannabis production.
• Regulatory Insights and Challenges: Dive into the intricacies of cannabis regulation from a federal perspective with Lisa's expert analysis. Learn how Maridose navigates the regulatory landscape, the implications of DEA licensing, and the future of cannabis legislation from someone at the forefront of the industry.
• The Future of Cannabis in Healthcare: Explore the potential of cannabis to transform healthcare with discussions on clinical research, the development of cannabinoid-based pharmaceuticals, and Maridose's vision for the future. Lisa provides a glimpse into the innovative projects Maridose is undertaking and how they're shaping the role of cannabis in medical and consumer markets.

With Eric, Isaac, and special guest Lisa Rich Milan, "Charting New Highs" promises a deep dive into the evolving world of cannabis, offering unique perspectives on its challenges, opportunities, and its promising future in healthcare.

Tune in for an episode that bridges the gap between cannabis culture and pharmaceutical rigor, shedding light on the path forward for the industry.